Upload
shahan-ullah
View
210
Download
1
Tags:
Embed Size (px)
DESCRIPTION
Antiviral protocols for dengue
Citation preview
Shahan Ullah Mphil Pharmacology
1
Shahan UllahMPhil Pharmacology
Cell-based Antiviral assays for screening and profiling
inhibitors against dengue virus
Institute of Basic Medical SciencesKhyber Medical University Peshawar
1
Shahan Ullah Mphil Pharmacology 2
DENGUE VIRUS CULTURING
Plaque reduction
Assay
High throughput Screening
assay
DENGUE VIRUS
Shahan Ullah Mphil Pharmacology
3
DENGUE
A mosquito borne virusBelongs to family FlaviviridaeCarriers are
Aedes aegypti Aedes albopictus
Endemic in more than hundred countries Southeast Asia Southern and Central America Carribean and south pacific regions
Shahan Ullah Mphil Pharmacology
4
DENGUE
2.5 billions people are living in areas at risk for dengue
50-100 millions infections/annum500,000 hospitalizations/annum24,000 deaths/annumNo effective antiviral therapy or vaccines are
available for itDengue infection ranges from dengue fever to
dengue shock syndromeThe therapy “if” exists is purely SUPPORTIVE
Shahan Ullah Mphil Pharmacology
5
DENGUE
Four related but distinct serotypes exist for dengue and transmit through mosquito bite
Its enveloped single stranded RNA virusIts genome encodes a single polyprotein that is cleaved
Cotranslationally Post translationally
By host Virus encoded protease
3 structural, 7 non structural proteins
But NS3 protease and NS5 RNA polymerase are best targets for antiviral drug therapy development As experienced for HCV and HIV
Shahan Ullah Mphil Pharmacology
6
Dengue virus culturing
Requirements: Vero cells (African green monkey kidney cells) BHK-21 cells (baby hamster kidney cells) DENV-2 (serotype 2) NGC (New Guinea C) strain Eagle’s minimum essential medium (MEM) without L -
glutamine. MEM without L -glutamine and sodium bicarbonate Heat-inactivated fetal calf serum (FCS). 200 mM L -glutamine. Gentamicin solution (50 mg/mL). 100 mM sodium pyruvate MEM nonessential amino acids 0.05 % trypsin–EDTA.
Shahan Ullah Mphil Pharmacology
7
Cells, virus and reagents
Vero cell growth medium (MEM/10 % FCS): Eagle’s MEM supplemented with 10 % FCS, 2
mM L-glutamine, and 0.02 mg/mL gentamicin.
Vero cell maintenance medium (MEM/2 % FCS): Same as the growth medium but supplemented with
2 % FCS.BHK-21 cell growth medium:
Eagle’s MEM supplemented with 10 % FCS, 2 mM L - glutamine , 1× MEM nonessential amino acids, 1× sodium pyruvate, and 0.02 mg/mL gentamicin.
Shahan Ullah Mphil Pharmacology
8
Cells, virus and reagents
BHK-21 cell maintenance medium supplemented with 2 % FCS.
BHK-21 cell maintenance medium MEM without L -glutamine and sodium
bicarbonate Dulbecco’s phosphate-buffered saline (D-
PBS), (no calcium chloride, no magnesium chloride)
10 % formalin in D-PBS.1 % crystal violet solution (Sigma-Aldrich).
Shahan Ullah Mphil Pharmacology
9
Cells, virus and reagents
1.5 % methylcellulose in water: Weigh 1.5 g of methylcellulose in an Erlenmeyer flask and add 100
mL of deionized H2O into the flask. Place the cap loosely on the bottle. Put a stirring bar into the flask and place on a magnetic stirrer. Heat the
flask under stirring until boiling.Then allow the flask to cool to
room temperature. Continue stirring the flask overnight.
Trypan blue stain ATPLite™ 1-step kitReference compounds:
(a) Interferon α-2a (Roferon A, Roche).(b) 6-Azauridine (Sigma-Aldrich).(c) 2′-C-Methylcytidine (Sigma-Aldrich).(d) Ribavirin (Sigma-Aldrich).
Shahan Ullah Mphil Pharmacology
10
Consumables
1. 6-well, flat-bottom plates: Corning ® Costar ® cell culture plates.
2. Nunc ® TripleFlasks (F8542, Sigma-Aldrich) .
3. Greiner Lumitrac 384-well plate (VWR).4. White-view 384-well plates
(white wall and transparent bottom)
5. Absorbent pad.
Shahan Ullah Mphil Pharmacology
11
Equipments
1. Centrifuge.2. Magnetic stirrer.3. Multidrop combi liquid dispenser (Thermo
Scientifi c).4. ViewLux™ (a luminescent reader)5. Cell counter (Coulter Electronics LTD)
(optional).6. Microplate shaker.7. Light-box.
Shahan Ullah Mphil Pharmacology 12
12
Shahan Ullah Mphil Pharmacology
13
Viral culturing
Procedure:1. Seed Vero cells in T175 flasks using the Vero cell growth
medium and incubate at 37 °C in a humidified 5 % CO 2 incubator overnight . The cell monolayer should be sub-confluent (~90 %) on the following
day.
2. On the following day:prepare a viral dilution at a multiplicity of infection (MOI)
of 0.1 TCID 50 /cell in MEM/2 % FCS. Prepare 15 mL of virus dilution for each flask to be infected.
3. Remove the old culture medium from flasks and wash the sub-confluent cells once with D-PBS.
Shahan Ullah Mphil Pharmacology
14
Viral culturing
4. Add 15 mL of the viral dilution to each flask.
5. Swirl the flask gently to spread the viral inoculum evenly to the whole-cell monolayer.
6. Incubate the cells at 37 °C, 5 % CO 2 , for 2 h with occasional swirling.
7. Discard the viral inoculum.
8. Rinse the infected cells once with D-PBS.
9. Add 18 mL of fresh MEM/2 % FCS to each flask incubate the infected cells at 37 °C, 5 % CO 2 , wait for 5–6 days until the viral cytopathic effect (CPE) reaches ~90–100
%.
Shahan Ullah Mphil Pharmacology
15
Viral culturing
10. Collect the supernatant into sterile 50 mL Falcon tubes and centrifuge at 3,700 × g and 4 °C for 10 min to remove the cell debris.
11. After centrifugation; pool the supernatants from all falcon tubes into a sterile
bottle or a fresh T175 flask.12. Add heat-inactivated 20%FCS to the harvested
supernatant
Aliquot 1 mL to each cryovial and store in a −80 °C freezer.
16
Plaque reducing assay
1. Prepare a BHK-21 cell suspension at a density of 1.0 × 10 5 cells/mL in BHK-21 cell growth medium.
2. Seed 6-well plates with 3mL of the BHK-21 cell suspension per well Final value 3 × 10 5 cells/well. Prepare duplicate wells for
each test compound concentration.
3. Incubate the plate at 37 °C, 5 % CO 2 , overnight.
4. On the following day, check the BHK-21 cells with a microscope. The cell monolayer should be
sub-confluent (~90 %). 5. Thaw a DENV stock quickly
at 37 °C in a water-bath with shaking. Make an appropriate dilution of
the virus (100 PFU /mL) in the BHK-21 cell maintenance medium for plates.
6. Remove the old culture medium by inverting the plate over absorbent pad.
7. Rinse the cells with D-PBS once.
Shahan Ullah Mphil Pharmacology
Baby hamster
Shahan Ullah Mphil Pharmacology
17
Plaque reducing assay
8. Add 1 mL of diluted virus into each well (100 PFU per well).
9. Incubate the plates at 37 °C, 5 % CO 2 , for 1.5–2 h. Swirl the plates
periodically to spread the virus evenly over the cell monolayer.
10. During the incubation period; perform 5 or 10 fold serial
dilutions of test compounds in BHK21 cell growth media
Prepare methylcellulose overlay :
Test wells: 1.5% Methyl cellulose in
water + test compund + MEM Cell maintenance media 2% FCS
Control wells: 1.5% MC in water+ MEM cell
maintenance media 2% FCS Prepare enough volumes for
the duplicate wells.
18
Plaque reducing assay
11. Remove the viral inoculums from the plates by inverting the plates over an absorbent pad.
12. Add 3 mL/well of the MC overlay containing various test compounds to the corresponding wells of 6-well plates.
13. Add 3 mL of MC overlay containing no compound to the control wells.
14. Incubate the plates at 37 °C, 5 % CO 2 , for 4 days.
15. Remove the methylcellulose overlay from plates by inverting the plate over an absorbent pad.
16. Add 2 mL of 10 % formalin to each well to fix the cells Incubate at room temperature for 10 min.
17. Discard the formalin
18. Stain by adding 2–3 drops of 1.0 % crystal violet to each well. Leave at room temperature for 5–10 min.
19. Remove excess of crystal violet by rinsing the plates in a gentle tap water flow.
20. Air-dry the plates. 21. Place the plates upside
down on a light-box(plaque counter) Count the plaques in each
well using a colony counter, if more wells used then average it
22. Enter the data in a standard statistical program, such as GraphPad Prism Calculate, EC 50 of test
compounds
Shahan Ullah Mphil Pharmacology
Shahan Ullah Mphil Pharmacology
19
High-throughput antiviral assay for screening inhibitors of DENV
1. Seed enough Vero cells based on the number of test plates to be tested. The cells should be confluent at the
day of antiviral experiment . We typically culture the Vero
cells in triple flasks. three parallel growth surfaces with
a total culture area of 500 cm 2 .
2. Discard the old cell culture medium from a triple flask and rinse three cell monolayers with 60 mL D-PBS.
3. Add 15 mL of 0.05 % trypsin–EDTA to a triple flask and spread the solution over all three surfaces.
4. Pour off excess of trypsin and incubate the flask at 37 °C for 2–3 min.
5. Dislodge cells by tapping flask with the palm of hand.
6. Add 30 mL of Vero cell maintenance medium (MEM/2 % FCS) to the flask. Rock the flask to dislodge the cells
7. Collect the cell suspension in a sterile Falcon tube.
20
High-throughput antiviral assay for screening DENV inhibitors
8. Count the cells using either a cell counter or a trypan blue stain.9. For Activity plate: Prepare 5.8 mL of cell suspension, 15microlitre for each well
density of 1 × 10 5 cells/ mL for each 384-well (the optimal number of cells in each well is 1,500
10. For Toxicity plate:Prepare 11.6 mL of cell suspension, 30 μL for each well at a density of 5 × 10 4 cells/mL for each 384-well toxicity plate
11. Thaw a DENV-2 stock quickly in a 37 °C water-bath with shaking.
Make an appropriate dilution of the virus in MEM/2 % FCS to result in an MOI of 0.1 TCID 50 /cell.
Prepare 5.3 mL viral dilution for each 384-well activity plate (15 μL/well).
Shahan Ullah Mphil Pharmacology
Shahan Ullah Mphil Pharmacology
21
High-throughput antiviral assay for screening DENV inhibitors
12. In a biosafety cabinet, use a multidrop combi liquid dispenser for dispensing
ACTIVITY TEST PLATES: (a) Dispense 15 μL of
MEM/2 % FCS into the wells of columns 23 and 24 (cell controls).
(b) Dispense 15 μL of cell suspension into all wells of the test plate.
(c) Dispense 15 μL of the virus dilution into all wells of columns 1–22.
(d) Dispense test compound/s 15 μL into all wells of colunms 1-18
Toxicity test plates: (a) Dispense 30 μL of
MEM/2 % FCS into the wells of columns 23 and 24 (medium controls).
(b) Dispense 30 μL of cell suspension into all wells of columns 1–22.
Shahan Ullah Mphil Pharmacology
22
High-throughput antiviral assay for screening inhibitors of DENV
13. Incubate the plates at 37 °C, 5 % CO 2 , for 5–6 days.
14. After incubation, check the plates with reference compounds under an inverted microscope.
The CPE in the virus control wells should reach ~100 %.
The ATP levels in compound-treated and untreated cells are measured by a luminescent assay using an ATPLite™ 1-Step kit.
We use ViewLux™ to measure the luminescence.
Shahan Ullah Mphil Pharmacology
23
High-throughput antiviral assay for screening inhibitors of DENV
The following procedures are recommended by the manufacturer: (a) Warm up all reagents to room temperature before use. (b) Reconstitute the lyophilized substrate solution by
adding the appropriate volume of buffer to the substrate bottle.
Mix the contents by inversion and leave the solution to stand for 5 min
(c) Add 40 μL of the reconstituted reagent to each well of activity and toxicity plates using a multidrop combi liquid dispenser
(d) Shake the plates for 2 min at 700 rpm using an orbital microplate shaker.
(e) Program Viewlux to take a 0.1-s integrated reading of each plate.
Shahan Ullah Mphil Pharmacology
24
High-throughput antiviral assay for screening DENV inhibitors
15. Export the test results to an Excel sheet.
Calculate the percentage of inhibition based on the reduction of the luminescent signals in the compound-treated wells relative to the cell controls.
If duplicate or quadruplicate wells are used for each drug concentration, average the luminescent readings in those wells.
Calculate the EC 50 and CC 50 of test compounds using computer software, such as GraphPad Prism.
Shahan Ullah Mphil Pharmacology 25
HAVE A
NIC
E
DAY…
TH
AN
KS…
!SH
AH
AN